Two Sigma Investments
SLS icon

Two Sigma Investments’s SELLAS Life Sciences SLS Stock Holding History

Two Sigma Investments’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Sell
403,165
-679,042
-63% -$3.04M ﹤0.01% 2879
2025
Q4 		$4.08M Buy
1,082,207
+936,351
+642% +$1.82M 0.01% 1897
2025
Q3 		$235K Sell
145,856
-51,786
-26% -$92.2K ﹤0.01% 3319
2025
Q2 		$433K Buy
197,642
+149,355
+309% +$229K ﹤0.01% 2648
2025
Q1 		$52.1K Buy
+48,287
New +$57.3K ﹤0.01% 3041
2024
Q4 		– Sell
-16,591
Closed -$20.7K – 3458
2024
Q3 		$20.7K Buy
+16,591
New +$20.3K ﹤0.01% 3020
2022
Q4 		– Sell
-53,685
Closed -$108K – 3059
2022
Q3 		$108K Buy
53,685
+32,191
+150% +$88.9K ﹤0.01% 2220
2022
Q2 		$48K Buy
+21,494
New +$63K ﹤0.01% 2351

Other funds holding SLS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM